Ranking · Summer 2018 · Healthcare · Consumer Health and Wellness

Mark Cuban Cost Plus Drug Company, PBC

Making low cost versions of high cost generic drugs.

5.3%

odds of being acquired in the next two years

0.8× the average (6.8%)

#3244 of 4,339 active YC companies · top 76%

Team size not listed · Dallas, TX, USA

Raises the odds

↑ based in United States of America

↑ based in America / Canada

↑ changed its name (pivot)

Lowers the odds

↓ industry: Healthcare

↓ team size not listed

From the model: how this company's profile compares with companies that were and weren't acquired since 2024. How it works.

Signals brief

ExitOdds reads Mark Cuban Cost Plus Drug Company, PBC's website and YC profile; Contextrie keeps the passages that bear on an acquisition, and every signal quotes its source.

3 free briefs left today

costplusdrugs.com YC profile

Statistical estimate from public directory data as of 2026-10-07; it can't see revenue, funding or talks. Not investment advice. ExitOdds is independent and not affiliated with Y Combinator.

Built with open source on GitHub